Cancer type | Country, no. of participants, treatment stage | Study design | Perceived benefits | Perceived risks | Reference | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Physiological benefits (A) Fitness, (B) Strength, (C) Promote health & recovery, (D) Boost energy, (E) Improve survival, (F) Prevent reoccurrence, & (G) Weight loss | Psychosocial benefits (H) Relieve stress, (I) Better state of mind, (J) Socialization, (K) Quality sleep, & (L) Self-esteem | (A) Fatigue, (B) Pain, & (C) Risk of injury | ||||||||||||||||
(A) | (B) | (C) | (D) | (E) | (F) | (G) | (H) | (I) | (J) | (K) | (L) | (A) | (B) | (C) | ||||
Breast | Canada, 9, post-ttt | QI | + | + | + | + | + | [40] | ||||||||||
Canada, 8, during ttt | QI | + | + | + | + | + | [49] | |||||||||||
Canada, 12, mixed | FG | + | + (25) | + (8) | + (17) | + | + (17) | + | + | + (17) | + | [50] | ||||||
Canada, 12, post-ttt | QI | + | + | + | + | + | + | + | [41] | |||||||||
NZ, 20 women | FG | + | + | [51] | ||||||||||||||
Norway, 27 women, during ttt | FG | + | + | + | + | + | + | [52] | ||||||||||
Sweden, 16, on ttt | QI | + | + | + | + | + | + | + | + | [53] | ||||||||
US, 60 women | QI | + (28) | + (15) | + (5) | + (18) | [54] | ||||||||||||
US, 23 women, during ttt | CS | + (91) | + (91) | + (78) | + (91) | + (87) | + (83) | + (52) | + (78) | + (30) | + (4) | [55] | ||||||
Colo-rectal | Australia,10, post-ttt | QI | + | + | + | + | + | + | + | [56] | ||||||||
Canada, 600, post-ttt | CS | + (70) | + (66) | + (61) | + (58) | + (41) | + (52) | + (54) | + (44) | [57] | ||||||||
Canada, 30, mixed | QI | + (75) | + (56) | + (63) | + (50) | + (50) | + (24) | + (31) | + (50) | + (65) | [58] | |||||||
Sweden, 17 patients | QI | + | [59] | |||||||||||||||
Endom-etrial | UK, 16 women, post-ttt | QI | + | + | + | + | [60] | |||||||||||
Kidney | Canada, 482, post-ttt | CS | + (26) | + (25) | + (22) | + (23) | + (49) | + (3) | + (24) | [61] | ||||||||
Leuke-mia | US, 6, post-ttt | QI | + | + | + | + | + | + | [62] | |||||||||
Lung | Australia, 7, post-ttt | FG | + | + | + | + | + | [63] | ||||||||||
Denmark, 19, post-ttt | QI | + | + | + | + | + | + | [64] | ||||||||||
US, 43, pre-ttt | CS | + (13) | + (67) | + (18) | + (13) | + (48) | + (29) | +(14) | [65] | |||||||||
Multiple myeloma | Australia, 24 patients, post-ttt | QI | + | + | + | + | + | + | [66] | |||||||||
Ovarian | Australia, 12, mixed | QI | + | + | [67] | |||||||||||||
Prostate | Australia, 18, post-ttt | QI | + | + | + | + | + | + | + | [68] | ||||||||
Ireland, 20 men | QI | + | + | + | + | + | [31] | |||||||||||
Variousa | Australia, 9, on ttt | QI/FG | + | + | + | + | [69] | |||||||||||
Australia, 15, mixed | QI | + | + | + | + | + | + | + | + | [70] | ||||||||
Australia, 102, post-ttt | CS | + (88) | + (96) | + (44) | + (63) | + (68) | + (61) | [71] | ||||||||||
Canada, 788 patients | CS | + (76) | + (90) | [22] | ||||||||||||||
Canada, 66, mixed | CS | + | + | + | + | + | + | [72] | ||||||||||
Canada, 13, post-ttt | QI | + | + | + | + | + | + | + | + | [73] | ||||||||
England, 59, mixed | CS | + (40) | + (40) | + (10) | + (16) | + (10) | ||||||||||||
Germany, 905 patients | CS | + (58) | + (68) | + (61) | [76] | |||||||||||||
Ireland, 41, mixed | FG | + | + | + | + | + | + | + | + | + | [77] | |||||||
Italy, 12 females, post-ttt | FG | + | + | [78] | ||||||||||||||
Netherlands, 13, post-ttt | QI | + | + | + | + | + | + | + | + | [79] | ||||||||
Norway, 7, on ttt | QI | + | + | + | + | + | [80] | |||||||||||
NZ, 25, mixed stages | QI | + | + | + | + | + | [81] | |||||||||||
Sweden, 18, during ttt | FG | + | + | + | + | + | + | + | + | + | + | [24] | ||||||
UK, 6, post-ttt | QI | + | + | + | + | + | + | + | + | + | [82] | |||||||
UK, 19, post-ttt | QI | + | + | + | + | [37] | ||||||||||||
UK, 16, mixed | QI | + | + | + | + | [83] | ||||||||||||
UK, 26, mixed | FG | + | + | + | + | + | + | + | + | [84] | ||||||||
UK, 456 patients | CS | + (87) | + (54) | [43] | ||||||||||||||
US, 20, during ttt | QI | + | + | + | + | + | + | [85] | ||||||||||
US, 25, post-ttt | FG | + | + | [86] |